Literature DB >> 25605033

Esophageal atresia and transitional care--step 1: a systematic review and meta-analysis of the literature to define the prevalence of chronic long-term problems.

Martin J Connor1, Laurie R Springford1, Venediktos V Kapetanakis2, Stefano Giuliani3.   

Abstract

BACKGROUND: Esophageal atresia (EA) is a rare congenital anomaly with high infantile survival rates. The aim of this study was to outline the prevalence of common long-term problems associated with EA repair in patients older than 10 years of age. DATA SOURCES: Original papers were identified by systematic searching of MEDLINE and EMBASE databases from January 1993 to July 2014. Fifteen articles (907 EA patients) met inclusion criteria.
CONCLUSIONS: This is the first systematic review aiming to quantify the prevalence of the long-term problems associated with EA. The main active medical conditions (pooled estimated prevalence) identified were the following: dysphagia (50.3%), gastroesophageal reflux disease with (40.2%) or without (56.5%) histological esophagitis, recurrent respiratory tract infections (24.1%), doctor-diagnosed asthma (22.3%), persistent cough (14.6%), and wheeze (34.7%). The prevalence of Barrett's esophagus (6.4%) was 4 and 26 times higher than the adult (1.6%) and pediatric (.25%) general populations. Adult and pediatric practitioners should focus on how to develop effective long-term follow-up and transitional care for these patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Barrett’s esophagus; Esophageal atresia; Esophageal cancer; Gastroesophageal reflux; Long-term care; Review

Mesh:

Year:  2014        PMID: 25605033     DOI: 10.1016/j.amjsurg.2014.09.019

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  15 in total

Review 1.  Surveillance in Patients With Esophageal Atresia/Tracheoesophageal Fistula.

Authors:  Arunjot Singh; William Middlesworth; Julie Khlevner
Journal:  Curr Gastroenterol Rep       Date:  2017-01

2.  Postoperative Complications and Functional Outcome after Esophageal Atresia Repair: Results from Longitudinal Single-Center Follow-Up.

Authors:  Florian Friedmacher; Birgit Kroneis; Andrea Huber-Zeyringer; Peter Schober; Holger Till; Hugo Sauer; Michael E Höllwarth
Journal:  J Gastrointest Surg       Date:  2017-04-19       Impact factor: 3.452

Review 3.  How to Care for Patients with EA-TEF: The Known and the Unknown.

Authors:  Hayat Mousa; Usha Krishnan; Maheen Hassan; Luigi Dall'Oglio; Rachel Rosen; Frédéric Gottrand; Christophe Faure
Journal:  Curr Gastroenterol Rep       Date:  2017-11-25

Review 4.  Feeding Difficulties in Children with Esophageal Atresia.

Authors:  Lisa Mahoney; Rachel Rosen
Journal:  Paediatr Respir Rev       Date:  2015-06-24       Impact factor: 2.726

5.  Long-term morbidity in adolescents and young adults with surgically treated esophageal atresia.

Authors:  Hiroomi Okuyama; Yuko Tazuke; Takehisa Uenoa; Hiroaki Yamanaka; Yuichi Takama; Ryuta Saka; Keigo Nara; Noriaki Usui
Journal:  Surg Today       Date:  2016-12-27       Impact factor: 2.549

6.  Gastrointestinal Dysmotility and the Implications for Respiratory Disease.

Authors:  Lusine Ambartsumyan; Samuel Nurko; Rachel Rosen
Journal:  Curr Treat Options Pediatr       Date:  2019-04-26

Review 7.  Dysmotility in Esophageal Atresia: Pathophysiology, Characterization, and Treatment.

Authors:  Christophe Faure; Franziska Righini Grunder
Journal:  Front Pediatr       Date:  2017-05-31       Impact factor: 3.418

Review 8.  Impedance Testing in Esophageal Atresia Patients.

Authors:  Maheen Hassan; Hayat Mousa
Journal:  Front Pediatr       Date:  2017-04-25       Impact factor: 3.418

Review 9.  Aspiration Risk and Respiratory Complications in Patients with Esophageal Atresia.

Authors:  Thomas Kovesi
Journal:  Front Pediatr       Date:  2017-04-03       Impact factor: 3.418

Review 10.  Feeding Problems and Their Underlying Mechanisms in the Esophageal Atresia-Tracheoesophageal Fistula Patient.

Authors:  Lisa Mahoney; Rachel Rosen
Journal:  Front Pediatr       Date:  2017-05-31       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.